AGIOS PHARMACEUTICALS, INC.
Ownership & governance
Executives 5Directors 10Avg age 60Avg tenure 5.2y
BG
Brian Goff
Chief Executive Officer
Age 57Since 2022-08-07Profile →
+14
Executives5
BG
Brian Goff→
Chief Executive Officer
Age 57Since 2022-08-07
CJ
Cecilia Jones→
Director of Finance/CFO
Age 51Since 2022-09-25
SG
Sarah Gheuens
Chief Tech/Sci/R&D Officer
Age 47Since 2021-08-31
CP
Clive Patience
Chief Tech/Sci/R&D Officer
Age 62Since 2021-12-31
MS
Morgan Sanford
Investor Relations Contact
——
Board of directors10
KF
Kaye Foster-Cheek→
Director/Board Member
Age 66Since 2014-12-08
MH
May Kin Ho→
Director/Board Member
Age 73Since 2015-06-22
DS
David Scadden→
Director/Board Member
Age 73Since 2017-05-26
JF
Jacqualyn Fouse→
Chairman
Age 64Since 2022-08-07
BG
Brian Goff→
Director/Board Member
Age 57Since 2022-08-07
RB
Rahul Ballal→
Director/Board Member
Age 48Since 2022-08-10
CS
Cynthia Smith→
Director/Board Member
Age 57Since 2022-08-10
JC
Jeffrey Capello→
Director/Board Member
Age 61Since 2023-05-31
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Farallon Capital Management LLC | 9.558 % | 5,684,000 |
| BlackRock Advisors LLC | 8.867 % | 5,273,329 |
| STATE STREET CORPORATION | 5.658 % | 3,364,879 |
| D. E. Shaw & Co. LP | 5.102 % | 3,034,031 |
| Lynx1 Capital Management LP | 5.068 % | 3,013,949 |
Catalog · 2026-07-09
Proxy officers21
| Name | Role | Since | Shares |
|---|---|---|---|
| Jacqualyn Fouse | Chairman | 2022-08-07 | - |
| Brian Goff | Director/Board Member | 2022-08-07 | - |
| Catherine Adams | Director/Board Member | 2023-06-12 | - |
| Cecilia Jones | Director or executive officer | — | 223,373 |
| Cynthia Smith | Director or executive officer | 2022-08-01 | 78,720 |
| Cynthia Smith | Director/Board Member | 2022-08-10 | - |
| David Scadden | Director/Board Member | 2017-05-26 | - |
| David Scadden, M.D | Director or executive officer | 2017-12-01 | 130,845 |
Proxy · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus buyMean target 46Range 32–73Analysts 8
32Mean 4673
- Buy 7
- Hold 3
Broker actions40 of 142
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Truist Securities | Maintained | Buy | 37 | 2026-10-07 |
| B of A Securities | Maintained | Buy | 50 | 2026-09-21 |
| JP Morgan | Maintained | Neutral | 34 | 2026-08-07 |
| Citigroup | Maintained | Buy | 52 | 2026-07-31 |
| Truist Securities | Maintained | Buy | 39 | 2026-07-31 |
| HC Wainwright & Co. | Maintained | Buy | 55 | 2026-07-30 |
| HC Wainwright & Co. | Maintained | Buy | 52 | 2026-07-21 |
| RBC Capital | Maintained | Sector Perform | 32 | 2026-07-07 |
| Truist Securities | Maintained | Buy | 41 | 2026-07-07 |
| B of A Securities | Maintained | Buy | 46 | 2026-07-07 |
| HC Wainwright & Co. | Reiterated | Buy | 54 | 2026-06-15 |
| JP Morgan | Maintained | Neutral | 31 | 2026-06-11 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.